Joint Formulary & PAD

Scheriproct - Haemorrhoids

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Green
Formulations :
  • Ointment
  • Suppositories
Associated Icons :
SPC
Restrictions / Comments :
Important
Preferred
Scheriproct ointment and suppositories are considerably less expensive than Proctosedyl and Anusol HC in primary care.

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Scheriproct
Indication :
Haemorrhoids
Group Name :
Keywords :
haemorrhoid creams, haemorrhoid ointments, haemorrhoidal treatments
Brand Names Include :
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0

Other Indications

Below are listed other indications that Scheriproct is used to treat.

  • No records returned.

Other Drugs

Below are listed other drugs that are used to treat Haemorrhoids.

Committee Recommendations (1)

Scheriproct ointment and suppositories have been agreed as appropriate for initiation in Primary Care and/or continued in Primary Care following a recommendation from specialists in other health care sectors. Following consideration by the PCN, it has been assigned a GREEN traffic light status.

Scheriproct ointment and suppositories are considerably less costly than other brand equivalents such as Proctosedyl, Xyloproct, Uniroid HC and Ultraproct